- Sponsored Content
There is More Around in Biologics Than Cell Culture: Boehringer Ingelheim's Expertise in Microbial Technology
BPI Contributor
October 12, 2023
Sponsored Content
This interview features: Cécile Brocard, PhD, Director Downstream Development, Biopharma Process Science, Boehringer Ingelheim RCV GmbH, from Cell & Gene Manufacturing and Commercialization US 2023.
About the Author(s)
You May Also Like
Upcoming Webcasts
Insider News
From healthcare to health: 'No country can do this alone,' say experts in UAE
May 14, 2024|2 Min ReadUS looks to 2032 as cut-off from Chinese biomanufacturing reliance
May 13, 2024|3 Min ReadExacellGene and Cytovance partner to advance CHO and HEK cells
May 13, 2024|2 Min ReadAt a “tipping point” in history: Microsoft predicts AI revolution in healthcare
May 13, 2024|3 Min Read
Jun 17 - Jun 20, 2024
Jun 17 - Jun 20, 2024
Our Biopharmaceutical School is the perfect course to gain a well-rounded understanding of the Biopharmaceutical industry. Over three days, you will understand the principle steps in the biopharmaceutical lifecycle, including: raw material selection, up and downstream processes and core technology. Additionally, you will be familiarised with the latest industry trends, including Industry 4.0, and how these are likely to impact the industry’s evolution.
Through a combination of sessions led by experts from the likes of GSK and Pall Biotech, as well as group discussions with your peers, you will learn how to bring a biopharmaceutical drug to market. Each day will be chaired by a different member of the BioProcess International Academy faculty and there will also be time for networking and Q&As with the experts.
Learn More